Celsis Adapt™ Concentrator System for Rapid Microbial Detection of Cell-Based Products

Wednesday, July 27, 2022

The Celsis Adapt™ system provides cell-based sample preparation followed by analysis using the Celsis® ATP-bioluminescence platform. With the advent of the Celsis Adapt™ and the accompanying Celsis Adapt™ Cell Kit, both biopharma and cell therapy manufacturers can now utilize Celsis® for rapid contamination detection for sterility and in-process testing.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.